Oncology
Chemoembolization improves survival for many with unresectable liver cancer
Published in Hepatitis Weekly, January 12th, 2004
According to recent research from Spain, "hepatocellular carcinoma (HCC) is the fifth most common cause of cancer, and its incidence is increasing worldwide because of the dissemination of hepatitis B and C virus infection. Patients with cirrhosis are at the highest risk and should be monitored every 6 months. Surveillance can lead to diagnosis at early stages, when the tumor might be curable by resection, liver transplantation, or percutaneous treatment."
"In the West and Japan, these treatments can be applied to 30% of patients, and result in 5-year survival rates higher...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-01-12)
More Articles from Hepatitis Weekly
- Hepatitis C Therapy
Consolidation therapy improves sustained response in HCV genotype 1b patients - Cirrhosis
TIPS improves cardiac function in hypovolemic patients - Collaborations
Nonexclusive HCV license granted to Boehringer Ingelheim - Finance
Drug discovery company announces 2003 net loss of $3,925,000 - Finance
Gene identification company reports 73.7% gross profit margin - Gastroenterology
TNF-alpha may play an early role in the malignant transformation of liver cells - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
